Diversity of Acinetobacter baumannii in four French military hospitals, as assessed by multiple locus variable number of tandem repeats analysis
- PMID: 22984530
- PMCID: PMC3440325
- DOI: 10.1371/journal.pone.0044597
Diversity of Acinetobacter baumannii in four French military hospitals, as assessed by multiple locus variable number of tandem repeats analysis
Abstract
Background: Infections by A. calcoaceticus-A. baumannii (ACB) complex isolates represent a serious threat for wounded and burn patients. Three international multidrug-resistant (MDR) clones (EU clone I-III) are responsible for a large proportion of nosocomial infections with A. baumannii but other emerging strains with high epidemic potential also occur.
Methodology/principal findings: We automatized a Multiple locus variable number of tandem repeats (VNTR) analysis (MLVA) protocol and used it to investigate the genetic diversity of 136 ACB isolates from four military hospitals and one childrens hospital. Acinetobacter sp other than baumannii isolates represented 22.6% (31/137) with a majority being A. pittii. The genotyping protocol designed for A.baumannii was also efficient to cluster A. pittii isolates. Fifty-five percent of A. baumannii isolates belonged to the two international clones I and II, and we identified new clones which members were found in the different hospitals. Analysis of two CRISPR-cas systems helped define two clonal complexes and provided phylogenetic information to help trace back their emergence.
Conclusions/significance: The increasing occurrence of A. baumannii infections in the hospital calls for measures to rapidly characterize the isolates and identify emerging clones. The automatized MLVA protocol can be the instrument for such surveys. In addition, the investigation of CRISPR/cas systems may give important keys to understand the evolution of some highly successful clonal complexes.
Conflict of interest statement
Figures



Similar articles
-
Endemic and epidemic Acinetobacter baumannii clones: a twelve-year study in a tertiary care hospital.BMC Microbiol. 2015 Feb 25;15:47. doi: 10.1186/s12866-015-0383-y. BMC Microbiol. 2015. PMID: 25887224 Free PMC article.
-
Molecular epidemiology of multidrug-resistant Acinetobacter baumannii isolates in a university hospital in Nepal reveals the emergence of a novel epidemic clonal lineage.Int J Antimicrob Agents. 2015 Nov;46(5):526-31. doi: 10.1016/j.ijantimicag.2015.07.012. Epub 2015 Aug 28. Int J Antimicrob Agents. 2015. PMID: 26362951
-
OXA-Carbapenemases Present in Clinical Acinetobacter baumannii-calcoaceticus Complex Isolates from Patients in Kurdistan Region, Iraq.Microb Drug Resist. 2016 Dec;22(8):627-637. doi: 10.1089/mdr.2015.0060. Epub 2016 Mar 22. Microb Drug Resist. 2016. PMID: 27003287
-
Acinetobacter baumannii: evolution of a global pathogen.Pathog Dis. 2014 Aug;71(3):292-301. doi: 10.1111/2049-632X.12125. Epub 2014 Jan 27. Pathog Dis. 2014. PMID: 24376225 Review.
-
Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages.Int J Antimicrob Agents. 2013 Jan;41(1):11-9. doi: 10.1016/j.ijantimicag.2012.09.008. Epub 2012 Nov 3. Int J Antimicrob Agents. 2013. PMID: 23127486 Review.
Cited by
-
Features of Variable Number of Tandem Repeats in Yersinia pestis and the Development of a Hierarchical Genotyping Scheme.PLoS One. 2013 Jun 21;8(6):e66567. doi: 10.1371/journal.pone.0066567. Print 2013. PLoS One. 2013. PMID: 23805236 Free PMC article.
-
Crucial Role of the Accessory Genome in the Evolutionary Trajectory of Acinetobacter baumannii Global Clone 1.Front Microbiol. 2020 Mar 18;11:342. doi: 10.3389/fmicb.2020.00342. eCollection 2020. Front Microbiol. 2020. PMID: 32256462 Free PMC article.
-
Comparison of molecular typing methods for the analyses of Acinetobacter baumannii from ICU patients.Diagn Microbiol Infect Dis. 2016 Dec;86(4):345-350. doi: 10.1016/j.diagmicrobio.2016.08.024. Epub 2016 Aug 27. Diagn Microbiol Infect Dis. 2016. PMID: 27640081 Free PMC article.
-
Multidrug-Resistant Acinetobacter baumannii Genetic Characterization and Spread in Lithuania in 2014, 2016, and 2018.Life (Basel). 2021 Feb 16;11(2):151. doi: 10.3390/life11020151. Life (Basel). 2021. PMID: 33669401 Free PMC article.
-
Endemic and epidemic Acinetobacter baumannii clones: a twelve-year study in a tertiary care hospital.BMC Microbiol. 2015 Feb 25;15:47. doi: 10.1186/s12866-015-0383-y. BMC Microbiol. 2015. PMID: 25887224 Free PMC article.
References
-
- Dijkshoorn L, Nemec A, Seifert H (2007) An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii . Nat Rev Microbiol 5: 939–951. - PubMed
-
- Nemec A, De Baere T, Tjernberg I, Vaneechoutte M, van der Reijden TJ, et al. (2001) Acinetobacter ursingii sp. nov. and Acinetobacter schindleri sp. nov., isolated from human clinical specimens. Int J Syst Evol Microbiol 51: 1891–1899. - PubMed
-
- Nemec A, Krizova L, Maixnerova M, van der Reijden TJ, Deschaght P, et al. (2011) Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU). Res Microbiol 162: 393–404. - PubMed
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Molecular Biology Databases